Covalent Peptide‐Graphene Conjugates for Enhanced Cell Spreading, Osteogenic Differentiation, and Angiogenesis in Bone Defects
ChemBioChem · 2025
DOI: 10.1002/cbic.202500210 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Michelle E Wolf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Carnegie Mellon University, Mellon Institute, 4400 Fifth Ave, Pittsburgh, PA, 15213, USA. Hauptthemen laut MEDLINE: Graphite, Osteogenesis, Neovascularization, Physiologic, Peptides. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
Traumatic bone injury is one of the most common injuries that require surgical intervention, and current treatments suffer severe drawbacks. Modern research in bone regeneration focuses on implants that will support and enhance native tissue regeneration. One scaffold material that shows promise is graphene oxide (GO), a 2D nanomaterial made from oxidation of graphite. GO is biocompatible, strong, osteoinductive, is safely and slowly resorbed by the body, has a cheap, facile, and scalable synthesis, and is highly tailorable and functionalizable. The bioactivity of GO can be enhanced via functionalization with biomolecules such as peptides, proteins, and small molecules. Here, short peptides RGD, DGEA, and KKGHK are covalently bound to GO through a Claisen modification (CG) to create new functional graphenic materials that are cell‐adhesive, osteogenic, and angiogenic, respectively. These peptide‐Claisen graphenes (peptide‐CGs) are found to be cytocompatible, to encourage cell spreading on the graphenic surface, to promote osteogenesis in stem cells, and to induce angiogenesis in vascular endothelial cells. They show promise as next‐generation bone regeneration scaffolds by overcoming challenges frequently faced by bone regeneration scaffolds, namely retaining implanted and recruited cells, promoting their survival, proliferation, and differentiation, and ensuring a sufficient oxygen and nutrient supply to new tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Carnegie Mellon University, Mellon Institute, 4400 Fifth Ave, Pittsburgh, PA, 15213, USA.
- Department of Computational Biology, Carnegie Mellon University, Mellon Institute, 4400 Fifth Ave, Pittsburgh, PA, 15213, USA.
- Department of Biomedical Engineering, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, PA, 15213, USA.
ORCID-Profile: Michelle E Wolf, Yaxuan Liu, Stefanie A Sydlik
Förderung
- National Science Foundation
Zitieren
APA
Wolf, M. E., Liu, Y., Orlando, J. D., Zhou, J., & Sydlik, S. A. (2025). Covalent Peptide‐Graphene Conjugates for Enhanced Cell Spreading, Osteogenic Differentiation, and Angiogenesis in Bone Defects. ChemBioChem. https://doi.org/10.1002/cbic.202500210
Vancouver
Wolf ME, Liu Y, Orlando JD, Zhou J, Sydlik SA. Covalent Peptide‐Graphene Conjugates for Enhanced Cell Spreading, Osteogenic Differentiation, and Angiogenesis in Bone Defects. ChemBioChem. 2025. doi:10.1002/cbic.202500210
BibTeX
@article{Wolf2025,
author = {Wolf, Michelle E and Liu, Yaxuan and Orlando, Jason D and Zhou, Jingzhi and Sydlik, Stefanie A},
title = {Covalent Peptide‐Graphene Conjugates for Enhanced Cell Spreading, Osteogenic Differentiation, and Angiogenesis in Bone Defects},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500210}
}
EUVIMED